Clinical Study

A Phase 3, Randomized, Double-Blind Study Comparing The Efficacy And Safety Of Sage-217 Plus An Antidepressant Versus Placebo Plus An Antidepressant In Adults With Major Depressive Disorder

Posted Date: Jan 6, 2021

  • Investigator: Caleb Adler
  • Specialties: Depression, Psychiatry/Psychology
  • Type of Study: Drug

This is a randomized, double-blind, parallel-group, placebo-controlled study in adults with MDD. The diagnosis of MDD must be made according to Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) Clinical Trial Version (SCID 5-CT) performed by a qualified healthcare professional.


Male Or Female Between 18 And 64 Years Of Age, Inclusive


Major Depressive Disorder (Mdd), Depression

For More Information:

Emily Rummelhoff

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.